Processa Pharmaceuticals Income Statement (2012-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Shares Outstanding (Entity) (Quarter)	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.05M	0.05M	0.05M	0.05M	0.11M	0.11M	0.13M	0.12M	0.38M	0.62M	2.11M	1.31M	2.68M
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	1.61M	1.72M	2.07M	2.04M	3.14M	3.14M	3.17M	1.63M	1.69M	1.15M	1.32M	1.54M	1.73M	2.29M	1.71M	1.59M	2.45M	1.66M	2.11M	1.81M
Selling, General & Administrative (Quarter)	1.33M	1.34M	1.30M	1.18M	2.03M	2.92M	2.63M	2.48M	1.03M	1.02M	1.15M	1.27M	1.35M	1.14M	1.02M	1.26M	1.50M	1.83M	1.59M	1.52M
Restructuring Costs (Quarter)																0.67M				0.68M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	2.94M	3.06M	3.37M	3.23M	5.17M	6.06M	5.80M	4.11M	2.71M	2.17M	2.47M	2.81M	3.08M	3.42M	2.73M	3.52M	3.95M	3.49M	3.70M	4.01M
Operating Income (Quarter)	-3.46M	-3.11M	-3.37M	-3.23M	-5.17M	-6.06M	-13.07M	-4.11M	-2.71M	-2.17M	-2.47M	-2.81M	-3.08M	-3.42M	-2.73M	-2.85M	-3.95M	-3.49M	-3.70M	-3.33M
EBIT (Quarter)	-3.46M	-3.11M	-3.37M	-3.23M	-5.17M	-6.06M	-13.07M	-4.11M	-2.71M	-2.17M	-2.47M	-2.81M	-3.08M	-3.42M	-2.73M	-2.85M	-3.95M	-3.49M	-3.70M	-3.33M
Non-operating items
Interest & Investment Income (Quarter)	0.00M	0.00M	0.00M	0.00M	0.01M	0.04M	0.06M			0.09M	0.06M	-0.08M		0.04M	0.24M	0.01M				0.01M
Other Non Operating Income (Quarter)				0.00M	0.01M			0.08M	0.10M			0.08M	0.07M	0.04M	-0.19M	0.01M	0.02M	0.05M	1.20M	-0.05M
Net income details
EBT (Quarter)	-3.29M	-3.11M	-3.37M	-3.23M	-5.16M	-6.02M	-13.01M	-4.02M	-2.61M	-2.27M	-20.04M	-3.03M	-3.01M	-3.48M	-2.50M	-2.83M	-3.95M	-3.49M	-3.70M	-3.38M
Tax Provisions (Quarter)	-0.14M	-0.12M	-0.18M
Profit After Tax (Quarter)	-3.16M	-2.99M	-3.18M	-3.23M	-5.16M	-6.02M	-13.01M	-4.02M	-2.61M	-2.08M	-2.40M	-2.73M	-3.01M	-3.38M	-2.73M	-2.83M	-3.93M	-3.44M	-3.40M	-3.38M
Income from Continuing Operations (Quarter)	-3.16M	-2.99M	-3.18M	-3.23M	-5.16M	-6.02M	-13.01M	-4.02M	-2.61M	-2.27M	-20.04M	-3.03M	-3.01M	-3.48M	-2.50M	-2.83M	-3.95M	-3.49M	-3.70M	-3.38M
Consolidated Net Income (Quarter)	-3.16M	-2.99M	-3.18M	-3.23M	-5.16M	-6.02M	-13.01M	-4.02M	-2.61M	-2.27M	-20.04M	-3.03M	-3.01M	-3.48M	-2.50M	-2.83M	-3.95M	-3.49M	-3.70M	-3.38M
Income towards Parent Company (Quarter)	-3.16M	-2.99M	-3.18M	-3.23M	-5.16M	-6.02M	-13.01M	-4.02M	-2.61M	-2.27M	-20.04M	-3.03M	-3.01M	-3.48M	-2.50M	-2.83M	-3.95M	-3.49M	-3.70M	-3.38M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-3.16M	-2.99M	-3.18M	-3.23M	-5.16M	-6.02M	-13.01M	-4.02M	-2.61M	-2.08M	-2.40M	-2.73M	-3.01M	-3.38M	-2.73M	-2.83M	-3.93M	-3.44M	-3.36M	-3.38M
Additional items
EPS (Basic) (Quarter)	-102.46	-96.17	-103.91	-101.92	-161.99	-185.82	-403.87	-88.32	-48.50	-38.55	-45.84	-27.63	-25.23	-25.83	-22.29	-7.44	-6.32	-1.81	-2.57	-1.29
EPS (Diluted) (Quarter)	-338.99	-320.76	-341.87	-346.52	-161.99	-185.82	-403.87	-88.31	-48.50	-38.55	-45.84	-27.63	-25.23	-25.83	-22.29	-7.44	-6.32	-1.81	-2.57	-1.29
Shares Outstanding (Quarter)	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.03M	0.05M	0.05M	0.05M	0.05M	0.10M	0.12M	0.13M	0.12M	0.38M	0.62M	1.90M	1.31M	2.62M
Shares Outstanding (Diluted) (Quarter)	0.01M	0.01M	0.01M	0.01M	0.03M	0.03M	0.03M	0.05M	0.05M	0.05M	0.05M	0.10M	0.12M	0.13M	0.12M	0.38M	0.62M	1.90M	1.31M	2.62M
EBITDA (Quarter)	-3.46M	-3.11M	-3.37M	-3.23M	-5.17M	-6.06M	-13.07M	-4.11M	-2.71M	-2.17M	-2.47M	-2.81M	-3.08M	-3.42M	-2.73M	-2.85M	-3.95M	-3.49M	-3.70M	-3.33M
Interest Expenses (Quarter)	0.00M	0.11M		0.00M	0.00M	0.07M	14.54M	0.23M	0.21M	0.19M	17.64M	0.14M	0.01M	0.09M			0.00M	0.00M	18.00
Tax Rate (Quarter)	4.16	3.94	5.40

Research Tools

Datasets

Plans

Developers

Processa Pharmaceuticals PCSA Income Statement (2012-2026)

Research Tools

Datasets

Plans

Developers

Processa Pharmaceuticals PCSA Income Statement (2012-2026)

Create an account

Sign In

Reset Password